Xtant Medical (NYSEARCA:XTNT) Slides After Q3 Revenue and EPS Miss Amid Strategic Review
Xtant Medical Reports Third Quarter 2026 Financial Results and Announces Board-led Strategic Review Process
Xtant Medical Hldgs Q3 EPS $(0.03) Misses $(0.02) Estimate, Sales $24.285M Miss $25.512M Estimate
Xtant Medical Says It No Longer Expects To Achieve Its Previously Issued FY26 Guidance; Co. Is Not Providing Revised FY26 Financial Guidance
Xtant Medical to Announce Third Quarter 2026 Financial Results on November 16, 2026
LUCID CAPITAL MARKETS Initiates Coverage On Xtant Medical Holdings with Buy Rating, Announces Price Target of $1
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market
Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand
Xtant Medical Holdings Inc (XTNT) (Q2 2026) Earnings Call Highlights: Strategic Expansion Amid ...
Xtant Medical Holdings, Inc. Q2 2026 Earnings Call Summary
Xtant Medical Reports Second Quarter 2026 Financial Results
Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript
Xtant Medical Hldgs Q2 Adj. EPS $(0.03) Misses $(0.02) Estimate, Sales $23.031M Miss $24.875M Estimate
Xtant Medical Hldgs Lowers FY2026 Sales Guidance from $101.000M-$105.000M to $99.000M-$103.000M vs $102.058M Est
Xtant Medical to Announce Second Quarter 2026 Financial Results on August 11, 2026
Xtant Medical to Participate in the Canaccord Genuity 46th Annual Growth Conference
Xtant Medical Q1 Earnings Call Highlights
Xtant Medical Holdings, Inc. Q1 2026 Earnings Call Summary
Xtant Medical Holdings Inc (XTNT) Q1 2026 Earnings Call Highlights: Navigating Challenges and ...
Xtant Medical Holdings, Inc. (XTNT) Q1 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.